Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Sodium-Glucose Cotransporter-2 Inhibitors Are Associated with Improved Survival in Patients with Cirrhosis.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: December 23, 2025
Empagliflozin versus dapagliflozin in patients with liver cirrhosis: A comparative real-world study on hepatic decompensation.
Journal: Hepatology forum
Published: December 16, 2025
Showing 1-2 of 2
Last Updated: 09/26/2026